This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

OMB grant reforms put commercialization pipeline at risk, stakeholders warn

By Melissa Ritti ( July 17, 2026, 20:17 GMT | Comment) -- Universities, trade groups, legal experts and technology transfer organizations say a planned rewrite of federal grant rules injects unprecedented uncertainty into the process through which government-funded research becomes patents, startups and license agreements. While the proposal would leave the Bayh-Dole Act untouched, it could weaken the research pipeline on which commercialization relies.An overhaul of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards — the regulations governing federal grant management in the US — has generated lopsided, and seemingly organic, opposition....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login